modelDenosumab_Sutjandra2011_reference
Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.
Information
| name: | denosumab |
| ATC code: | M05BX04 |
| model: | one compartment, IV dosing (PK_1C) |
| source: | Sutjandra L et al. 2011 |
| population: | healthy subjects and postmenopausal women with osteopenia or osteoporosis |
| measured compound: | denosumab |
| review: | curated candidate |
| record page: | pharmacolibrary-docs |
Parameters as reported in the paper
| parameter | value | unit | meaning |
|---|---|---|---|
| subcutaneous bioavailability of denosumab | 64 | % | Fab |
| k(a) | 0.00883 | h-1 | kel |
| central volume of distribution | 2.49 | L/66 kg | V |
| linear clearance | 3.06 | mL/h/66 kg | CLnorm |
About denosumab
Denosumab is a monoclonal antibody used to treat bone diseases, especially postmenopausal osteoporosis and bone loss linked to cancer. It is widely used and authorised in the European Union, with products covering osteoporosis, bone resorption, bone tumours, and giant cell tumour of bone.
Summary written by glm-5.3-flash from Wikidata Q408283 and the WHO ATC classification and the EMA medicines list; not checked by a person.
Identity, molar mass and metabolites: Denosumab.
References
Sutjandra L et al. (2011). Population pharmacokinetic meta-analysis of denosumab in healthy subjects and postmenopausal women with osteopenia or osteoporosis. Clinical pharmacokinetics 50(12):793–807. DOI:10.2165/11594240-000000000-00000 PUBMED:22087866
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Real | Cl_ref | 6.477563131313132e-09 | Cl [m3/s] |
| Real | Vd_ref | 0.0026409090909090913 | Vd [m3] |
| Modelica.Units.SI.Mass | weight (from PK_1C) | 75 | patient weight (kg) |
| Modelica.Units.SI.SpecificVolume | VdPerKg (from PK_1C) | 0.0009 | Volume of distribution per kg (default 0.9 L/kg) |
| Modelica.Units.SI.MassFraction | F (from PK_1C) | 1 | bioavailability (0-1) |
| Pharmacolibrary.Types.Clearance | Cl (from PK_1C) | 2.7777777777777776e-7 | clearance |
| Modelica.Units.SI.Time | adminTime (from PK_1C) | 60 | first administration time (s) |
| Modelica.Units.SI.Time | adminDuration (from PK_1C) | 600 | administration duration (s) |
| Modelica.Units.SI.Time | adminPeriod (from PK_1C) | 8*60*60 | period of administration (default 8 hours)(s) |
| Pharmacolibrary.Types.Mass | adminMass (from PK_1C) | 1e-4 | administration mass (mg) |
| Integer | adminCount (from PK_1C) | 8 | number of dose administered (1) |
| Pharmacolibrary.Types.Volume | Vd (from PK_1C) | VdPerKg*weight | Volume of distribution (m3) |
| Info › Therapeutic range (metadata, not used in equations) | |||
| Pharmacolibrary.Types.MassConcentration | Cmin (from PK_1C) | 0.004 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Cmax (from PK_1C) | 0.008 | maximal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Ctox_peak (from PK_1C) | 0.012 | toxicity peak level |
| Pharmacolibrary.Types.MassConcentration | Ctox_trough (from PK_1C) | 0.006 | toxicity trough level |
| Info › Substance metadata | |||
| Modelica.Units.SI.MolarMass | MM (from PK_1C) | 0 | molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0) |
| Info › Substance metadata (not used in equations) | |||
| Pharmacolibrary.Types.Dose | LD50 (from PK_1C) | 0 | median lethal dose [mg/kg]; 0 = unknown |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Types.ConcentrationOutput | C_central (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | centralCPort (from PK_1C) |
Components
| Type | Name | Default | Description |
|---|---|---|---|
| Pharmacokinetic.NoPerfusedTissueCompartment | central (from PK_1C) | ||
| Pharmacokinetic.ClearanceDrivenElimination | elim (from PK_1C) | ||
| Sources.PeriodicDose | periodicDose (from PK_1C) | ||
| Modelica.Units.SI.Time | t1_2 (from PK_1C) | central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models) |
Revisions
- 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Sutjandra_2011: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate